The present invention relates to the use of Opuntias, plant parts thereof and/or extracts or other preparations produced therefrom for the treatment of episodes of depression and depressive diseases or other affective disorders, which can be influenced by antidepressive agents, such as anxiety or panic disorders, bipolar depressions, somatization disorders and the premenstrual syndrome, as well as preliminary stages of such diseases.